News

Biotech it to the market: Indias Bioeconomy can reach $1.2 trillion by 2047 but only with bold capital-market reforms

India must create a special listing framework for research-stage companies on its stock exchanges. This will unlock capital for biotech and drug innovation. Hong Kong's success with a similar system shows the potential. This move will help retain talent and intellectual property within India. It is a strategic imperative for future growth.